Related Experiment Video
Updated: Aug 15, 2026

07:06
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
Published on: April 10, 2018
Hesitancy and Perceptions Regarding Dengue Vaccination Among Educated Ecuadorians
Matias Panchana-Lascano1,2, Flavio Veintemilla-Burgos2,3, Carlos Vela Velásquez1,2
1Universidad Católica Santiago de Guayaquil, Guayaquil, Ecuador.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|August 14, 2026
Summary
Most Ecuadorians find dengue vaccines safe, but hesitancy remains a challenge. Understanding perceptions is key to increasing dengue vaccine acceptance and coverage in Ecuador.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Dengue cases are rising globally and in Ecuador, with reported cases increasing from 27,906 in 2023 to 57,712 in 2024.
- Factors like socioeconomic disparities, climate change, and vaccine hesitancy impede dengue prevention efforts despite vaccine availability.
- This study investigates Ecuadorian population perceptions and reasons for dengue vaccine hesitancy.
Purpose of the Study:
- To analyze the perceptions of the Ecuadorian population regarding dengue vaccines.
- To explore underlying reasons contributing to dengue vaccine hesitancy in Ecuador.
Main Methods:
- A cross-sectional observational study adhering to STROBE guidelines.
- Online surveys distributed via Qualtrics app to eligible Ecuadorian adults (≥18 years, bachelor's degree minimum).
- Statistical analysis included descriptive percentages and chi-square tests (p < 0.05 significance).
Main Results:
- Out of 735 participants, 87.2% perceived dengue vaccines as safe, while 12.8% considered them unsafe.
- Overall willingness to be vaccinated was 75.9%.
- Perceived vaccine safety strongly correlated with vaccination willingness, region, and willingness to vaccinate offspring (p < 0.001), but not education or dengue knowledge/experience.
Conclusions:
- A majority of Ecuadorians perceive dengue vaccines as safe, yet hesitancy persists.
- Targeted educational initiatives are crucial for enhancing dengue vaccine acceptance and improving coverage rates.
Related Concept Videos
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Vaccinations
Overview
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
